Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
Journals
IJERPH
Special Issues
Prevention and Treatment of Cardiac and Cardiovascular Disease
ijerph-logo
Submit to IJERPH Review for IJERPH Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Prevention and Treatment of Cardiac and Cardiovascular Disease

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Global Health".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1401

Special Issue Editor

Dr. Piotr Rola

E-Mail Website
Guest Editor
1. Faculty of Health Sciences and Physical Culture, Witelon Collegium State University, 59-220 Legnica, Poland
2. Department of Cardiology, Provincial Specialized Hospital in Legnica, 59-220 Legnica, Poland
Interests: percutaneous coronary intervention; high-risk PCI; calcified lesion; shock wave Intravascular lithotripsy; rotational atherectomy; orbital atherectomy; bioresorbable scaffold; coronary artery diseases; left main diseases

Special Issue Information

Dear Colleagues,

Cardiac and cardiovascular diseases (CVDs) are major causes of death worldwide. They have resulted in the intensified effort of basic science and clinical investigators, key to developing novel therapeutic approaches to the prevention and treatment of CVDs. Despite undeniable progress in this field, CVDs remain a relevant clinical issue, and our knowledge in this area is insufficient. This Special Issue will highlight the latest findings in the field of the prevention and treatment of cardiac and cardiovascular diseases. Studies regarding the most common CVDs—coronary artery disease, heart failure, atrial fibrillation, stroke, hypertension, and peripheral artery diseases—particularly those evaluating novel medical devices, are highly recommended as a part of this Special Issue. Studies investigating novel invasive and non-invasive diagnostic tools are also welcomed. Additionally, the topic of this Special Issue will expand on novel prevention methods, diagnostic tools, and treatment protocols in post-COVID-19 pandemic reality. The authors are invited to contribute reviews, short communications, and original papers.

Please note that clinical studies not sufficiently addressing the aim of the journal will not be considered.

We look forward to receiving your contributions.

Dr. Piotr Rola
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery disease
  • heart failure
  • stroke
  • prevention
  • treatment methods
  • novel devices
  • cardiac diseases
  • cardiovascular diseases

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

11 pages, 352 KiB  
Article
Impact of Frailty on Healthcare Outcomes after Cardioembolic Ischaemic Stroke Due to Atrial Fibrillation
by Rónán O’Caoimh, Laura Morrison, Marion Hanley, Caoimhe McManus, Kate Donlon and Patricia Galvin
Int. J. Environ. Res. Public Health 2024, 21(3), 270; https://doi.org/10.3390/ijerph21030270 - 27 Feb 2024
Viewed by 1103
Abstract
Stroke due to atrial fibrillation (AF) is more common in older adults. Frailty is associated with AF. As little is known about the impact of frailty on cardioembolic stroke, we examined its association with important healthcare outcomes including mortality and functional outcome in [...] Read more.
Stroke due to atrial fibrillation (AF) is more common in older adults. Frailty is associated with AF. As little is known about the impact of frailty on cardioembolic stroke, we examined its association with important healthcare outcomes including mortality and functional outcome in stroke with AF. Data were collected from patients presenting consecutively to a regional university hospital to assess pre-admission frailty using the Clinical Frailty Scale (CFS) and function with the Modified Rankin Scale (mRS). Stroke severity was assessed on the National Institute of Health Stroke Scale (NIHSS). In total, 113 patients presenting between August 2014 and July 2016 were identified with cardioembolic stroke, median age 80 years; 60% were male. Their median NIHSS score was 6. The median pre-admission CFS score was 3; 26.5% scored ≥5/9, indicating frailty. The median pre-admission mRS scores increased significantly from 1 to 3 at discharge (p < 0.001). Frailty was associated with worse mRS scores at discharge, odds ratio 1.5, (p = 0.03). While no patients with frailty were suitable to avail of early supported discharge, 10% of those without frailty were (p = 0.02). There was no significant difference in 30-day mortality. Frailty is prevalent among patients with cardioembolic stroke due to AF and was associated with poorer functional outcomes. Although the numbers were small, these data suggest that brief frailty assessments are useful to risk-stratify patients with acute cardioembolic stroke. Frailty status on admission with stroke due to AF can help identify those more likely to have poorer outcomes, to benefit from intervention, to require prolonged rehabilitation, and to avail of ESD. Full article
(This article belongs to the Special Issue Prevention and Treatment of Cardiac and Cardiovascular Disease)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop